Antares Pharma (ATRS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2003 | 03-2003 | 12-2002 | 09-2002 | 06-2002 | |
| Sales | 908 | 910 | 965 | 1,233 | 1,129 |
| Cost of Goods | 569 | 503 | 478 | 874 | 559 |
| Gross Profit | 339 | 408 | 487 | 359 | 569 |
| Operating Expenses | 2,668 | 2,826 | 5,293 | 3,184 | 2,952 |
| Operating Income | -1,759 | -1,916 | -4,328 | -1,951 | -1,824 |
| Interest Expense | 227 | 311 | 830 | 415 | 45 |
| Other Income | -1,683 | -791 | -14 | -8 | -48 |
| Pre-tax Income | -3,670 | -3,018 | -5,172 | -2,373 | -1,917 |
| Net Income Continuous | -3,670 | -3,018 | -5,172 | -2,373 | -1,917 |
| Net Income | $-3,670 | $-3,018 | $-5,172 | $-2,373 | $-1,917 |
| EPS Basic Total Ops | -0.31 | -0.26 | -0.54 | -0.24 | -0.21 |
| EPS Basic Continuous Ops | -0.31 | -0.26 | -0.52 | -0.24 | -0.21 |
| EPS Diluted Total Ops | -0.31 | -0.26 | -0.54 | -0.24 | -0.21 |
| EPS Diluted Continuous Ops | -0.31 | -0.26 | -0.52 | -0.24 | -0.21 |
| EBITDA(a) | $-1,551 | $-1,696 | $-2,037 | $-1,732 | $-1,660 |